Allergy Immunotherapy Market: Size, Share & Growth Analysis 2034
Allergy Immunotherapy Market is experiencing substantial growth, reflecting a global surge in allergic conditions and an increasing preference for long-term treatment options. Allergy immunotherapy involves modifying the immune system’s response to allergens, offering sustainable relief for patients suffering from allergic rhinitis, asthma, food allergies, and insect venom allergies. By administering gradually increasing doses of specific allergens, therapies such as subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) help patients build long-term tolerance, improving quality of life and reducing the need for daily medications. In 2024, the market was estimated at 1.2 billion doses , and projections indicate it will reach 1.8 billion by 2028 . SLIT leads the way with a 45% share, thanks to its non-invasive nature and patient compliance benefits, while SCIT follows closely at 40%, supported by its proven long-term effectiveness....